جست‌وجوی استاد و پژوهشگر

Allan Davidمشاهده پروفایل

استاد

• Smart Materials
• Nanomedicine
• Cancer Research
• +۴ مورد دیگر

Allan David serves as the John W. Brown Professor of Chemical Engineering and Associate Dean for Research at Auburn University's Samuel Ginn College of Engineering. His leadership extends across academic administration and cutting-edge nanomedicine research, with a focus on translating laboratory discoveries into clinical applications. His educational foundation includes: Ph.D. in Chemical Engineering, University of Maryland B.S. in Chemical Engineering, University of Maryland Dr. David's research program pioneers nanomedicine applications through the development of smart materials for cancer diagnostics and therapy. His work spans nanoparticle-based MRI contrast agents , ocular drug delivery systems , and vaccine delivery platforms , with particular emphasis on optimizing physicochemical properties for targeted biological interactions. Current projects address critical healthcare challenges including safer contrast agents for patients with kidney impairment and precision cancer targeting mechanisms. Analysis of his 15 most recent publications reveals a cohesive research trajectory centered on magnetic nanoparticles and biomimetic delivery systems . The work demonstrates increasing translational focus, evolving from fundamental nanoparticle characterization (2020-2021) to clinically relevant applications like ocular delivery and cancer theranostics (2022-2024), culminating in commercialization efforts through NanoXort, LLC. Dr. David has secured significant research funding including an $184,773 grant from the Alabama Department of Economic and Community Affairs (ADECA) for developing cardiovascular MRI agents. He leads collaborative efforts that bridge chemical engineering with biomedical innovation, notably co-founding NanoXort, LLC to commercialize safer MRI contrast agents addressing gadolinium toxicity concerns for renal-impaired patients. His laboratory operates at the intersection of chemical engineering and medicine, focusing on nanoparticle-cell interactions and targeted delivery systems. The research group maintains strong industry partnerships through the NanoXort startup, which has secured $1 million NSF funding to advance MRI contrast agent technology toward clinical implementation.

• Oncology
• Molecular Biology
• Targeted Therapies
• +۳ مورد دیگر

Livio Trusolino is a Professor in the Department of Oncology at the University of Turin, affiliated with the Institute for Cancer Research and Treatment (IRCCS) in Candiolo. His research focuses on mechanisms of neoplastic transformation, growth factor receptor signaling, and preclinical models of targeted therapies, particularly in colorectal cancer. He leads courses such as 'Targeted Therapies in Colon Cancer' and contributes to the MD-PhD Program in Medicine. His work integrates molecular profiling (proteomics, genomics) with experimental models like patient-derived xenografts to study drug sensitivity and resistance. Key collaborations include projects on KRAS mutations, EGFR blockade, and drug combination therapies. He chairs academic bodies within the Department of Oncology and oversees the Molecular Pharmacology Laboratory. Recent research highlights include identifying biomarkers for therapeutic response and elucidating adaptive mutability in cancers. His contributions bridge basic science and clinical applications, advancing precision oncology strategies for colorectal cancer.

Kiemeney Lambertusمشاهده پروفایل

استاد

• Cancer Epidemiology
• Genetic Epidemiology
• Urological Cancers
• +۳ مورد دیگر

Kiemeney Lambertus is a Professor of Cancer Epidemiology at the Department of Health Evidence, Radboud University Medical Center in Nijmegen, Netherlands. He serves as Chair of the Department of Health Evidence and Scientific Director of the Radboud Institute for Health Sciences. His academic career includes roles as Head of the Department of Cancer Registry and Research, and Director of Research at the Netherlands Comprehensive Cancer Organisation. Lambertus holds a Master's in Biomedical Sciences (cum laude) from Radboud University and a Bachelor's in Physiotherapy (cum laude). His research focuses on urological cancers, genetic and clinical epidemiology, and biobanking. Key areas include prostate and bladder cancer genetics, risk prediction models, and validation of biomarkers like PCA3. He has pioneered studies on FGFR3 and JAG1 genes in bladder cancer susceptibility, and demonstrated the safety of coal tar treatments in dermatology. His over 500 publications include foundational work in genome-wide association studies (GWAS), with a Nature Genetics paper on bladder cancer susceptibility genes cited over 200 times. Lambertus has received global recognition including the Dominique Chopin Distinguished Researcher Award and inclusion in Thomson Reuters' most influential scientists list. Teaching Excellence: Multiple lecturer-of-the-year awards highlight his educational contributions. Leadership: Oversee large research institutes and national cancer initiatives. Global Impact: Collaborates with institutions worldwide, including Johns Hopkins University and the European Institute of Oncology. Current research emphasizes translational studies linking genetic discoveries to clinical outcomes, with a focus on reducing overdiagnosis in prostate cancer screening.

• Virology
• Molecular Pathology
• Host-Pathogen Interactions
• +۵ مورد دیگر

Dr. Richard Y. Zhao is a tenured Professor in the Department of Pathology and Microbiology-Immunology at the University of Maryland School of Medicine. His research combines molecular biology, fission yeast genetics, mammalian biology, and virology to study virus-host interactions, particularly for HIV and Zika virus. He previously held academic positions at Northwestern University and Columbia University and has contributed to over 120 peer-reviewed articles. B.S., China Oceanography University (1981) M.S., Oregon State University (1995) Ph.D., Oregon State University (1991) Postdoctoral Training, Columbia University (1991-1992) Dr. Zhao's research focuses on: Virus-host interactions and pathogenicity High-throughput drug screening for antivirals Role of viral proteins in neuroinflammation and cancer Translational genomics in precision medicine His recent publications highlight SARS-CoV-2 ORF3a, Zika envelope proteins, and HIV protease inhibitors, emphasizing host-pathogen mechanisms across species. He has served on NIH panels and editorial boards for journals like Cell Research and Retrovirology . Scientific awards include: Fellow, American Academy of Microbiology (2019) Bernard L Mirkin Endowed Chair (2001-2004) Honorary Director, Shandong Gallo Institute (2009) Distinguished Service from SCBA (2015) Outstanding Service from CBA-USA (2016) Dr. Zhao also contributes to clinical diagnostics and personalized medicine through molecular testing and pharmacogenetics programs.

Chad J Brennerمشاهده پروفایل

دانشیار

• Head and Neck Cancer
• HPV-Driven Oncogenesis
• Liquid Biopsy Technologies
• +۵ مورد دیگر

Dr. Chad J. Brenner is an Associate Professor in the Department of Otolaryngology-Head and Neck Surgery and Pharmacology at the University of Michigan Medical School. He also directs the U-M Program in Cellular and Molecular Biology, the Otolaryngology Clinical Laboratory (CLIA), and the Head & Neck Oncology Program. His research focuses on developing liquid biopsy tools for cancer detection and precision therapy, particularly in HPV-driven head and neck cancers. Key roles include membership in the Rogel Cancer Center, Kresge Hearing Research Institute, and Center for Computational Medicine & Bioinformatics. Education: B.S. in Biomedical Engineering, M.S. in Bioelectrical Engineering, and Ph.D. in Cellular and Molecular Biology from the University of Michigan, with doctoral work on prostate cancer mechanisms. Research Interests: HPV integration and cancer heterogeneity Urine- and blood-based liquid biopsies for real-time cancer monitoring Combination immunotherapy strategies for improving checkpoint inhibitor responses Genetic engineering to identify cancer vulnerabilities Clinical trial innovation for adaptive therapies Recent Work Highlights: Development of the MyHPVscore blood test for HPV-related head and neck cancer detection, and exploration of tumor-immune interactions through PD-L1 and T-cell profiling. Ongoing projects include PET-guided radiotherapy optimization and multi-omics analyses of tumor heterogeneity. Labs & Teams: Leads the Michigan Otolaryngology and Translational Oncology (MiOTO) lab and collaborates with interdisciplinary teams across computational medicine, immunology, and clinical oncology.

Ananias A. Escalanteمشاهده پروفایل

استاد

• Evolutionary Genomics
• Malaria Research
• Population Genetics
• +۳ مورد دیگر

Ananias A. Escalante is a Professor in the Department of Biology at Temple University's College of Science and Technology, and a core faculty member of the Institute for Genomics and Evolutionary Medicine (iGEM). He holds a PhD in Biology from the University of California, Irvine (1995), and has held roles at the CDC (1995–2005) and Arizona State University (2005–2015). His research integrates population genetics with epidemiology, focusing on malaria parasites' evolution, drug resistance mechanisms, and biodiversity. Key areas include Plasmodium falciparum resistance mutations, primate malaria origins, and molecular tools for surveillance. Education: PhD in Biology, University of California, Irvine (1995) MSc in Ecology, Universidad Simón Bolívar, Venezuela Bachelor's Degree in Biology, Universidad Simón Bolívar, Venezuela Research interests span evolutionary genomics, malaria parasite diversity, and the application of genomic tools to epidemiology. He investigates how genetic diversity in parasites influences drug resistance and transmission dynamics, with a focus on nonhuman primate malaria as a model for human malaria origins. His work includes phylogenetic studies of Plasmodium species and the development of mitochondrial genome protocols for pathogen analysis. Notable contributions include studies on Plasmodium vivax population genetics in the Americas, the impact of drug resistance mutations (e.g., pfhrp2/pfhrp3 deletions), and the molecular characterization of novel malaria parasites in reptiles and birds. He collaborates on initiatives like the Amazonian International Center of Excellence for Malaria Research. Advising and grants: While specific student names aren’t listed, his research team likely includes graduate students focused on evolutionary parasitology. Grants support projects on malaria genomics and vector ecology. He leads Temple’s iGEM lab, advancing interdisciplinary research in genomics and evolutionary medicine. Labs/Teams: Core faculty at Temple’s Institute for Genomics and Evolutionary Medicine (iGEM), collaborating on projects integrating genomics, epidemiology, and evolutionary biology.

• Cancer Immunology
• Immunotherapy
• Tumor Microenvironment
• +۳ مورد دیگر

Kelli Connolly is an Associate Research Scientist at the Yale School of Medicine, Yale University. Her research focuses on cancer immunology, with a particular emphasis on tumor immunity, T cell biology, and neoantigen-driven immune responses. She develops and utilizes mouse models to investigate mechanisms underlying anti-tumor immunity, including T cell exhaustion, tertiary lymphoid structures in cancer, and the role of stem-like T cells in sustaining immune responses. Her work bridges basic immunology and translational cancer research, aiming to improve immunotherapy strategies. Key Collaborations: Works closely with researchers like Nikhil Joshi, Gena Gora Foster, and Julie F. Cheung. Research Themes: Neoantigen expression, tumor-draining lymph node dynamics, and combination therapies targeting the immune microenvironment. Her studies highlight the importance of lineage fidelity in CD8 T cells and the role of transcription factors like KLF2 in suppressing exhaustion. She also explores how modulating chemokine axes (e.g., CCR2/CCR5) enhances radiotherapy efficacy. Connolly’s contributions span preclinical models for lung and pancreatic cancers, emphasizing the interplay between tumor biology and immunological mechanisms. Publications span journals like Science , Cell , and Nature Biotechnology , reflecting her impact in cancer immunology and translational research.

Yannic Nollerمشاهده پروفایل

استاد

• Automated Program Repair
• Machine Learning Analysis
• Software Testing
• +۳ مورد دیگر

Yannic Noller is a Professor at the Faculty of Computer Science at Ruhr University Bochum (RUB), leading the Software Quality group. Previously, he held positions as Assistant Professor at Singapore University of Technology and Design (SUTD) and Research Assistant Professor at National University of Singapore (NUS). His research focuses on automated software engineering, including program repair, machine learning analysis, and software testing. He earned his Ph.D. from Humboldt-Universität zu Berlin under Prof. Lars Grunske, with a thesis on hybrid differential software testing. Education: Ph.D. in Computer Science (2016-2020, Humboldt-Universität), M.Sc. (2013-2016, University of Stuttgart), B.Sc. (2010-2013, University of Stuttgart). Research interests include automated program repair techniques, machine learning model analysis, and intelligent tutoring systems for programming education. Notable contributions include HyDiff (hybrid differential analysis tool) and CPR (concolic program repair). Awards include the Distinguished Artifact Reviewer at ISSTA'2021 and multiple scholarships for academic excellence. Teaching includes courses on software engineering, requirements engineering, and automated software engineering.

• Verification and Validation
• Search-Based Software Engineering
• Autonomous Driving
• +۳ مورد دیگر

Shaukat Ali serves as Research Professor and Head of the Department of Engineering Complex Software Systems at Simula Research Laboratory, concurrently holding the title of Chief Research Scientist. His academic leadership drives innovation at the critical nexus of quantum computing, artificial intelligence, and software engineering, with concentrated expertise in verification, validation, and testing methodologies for complex systems including cyber-physical infrastructures and autonomous robotics. His primary research domains encompass: Verification and Validation Search-Based Software Engineering Autonomous Driving Systems Cyber-Physical Systems Engineering Digital Twin Technologies Quantum Software Engineering Analysis of recent publications (2024-2025) reveals a decisive trend toward quantum-AI convergence in software engineering, particularly through quantum software testing frameworks and AI foundation models applied to cyber-physical systems. His work systematically addresses noise mitigation in quantum hardware, uncertainty quantification in adaptive robotics, and novel testing paradigms using vision-language models for industrial robotics—demonstrating both theoretical rigor and industrial applicability. As department head, Ali spearheads strategic research directions in complex software systems, fostering cross-disciplinary collaboration while actively shaping quantum software engineering through workshops like QAI2024 and Q-SANER 2024. His invited presentations at venues including JYU Quantum Electronics and EU-Korea Quantum Forums underscore his influence in defining emerging research landscapes.

Ram Samudralaمشاهده پروفایل

استاد

• Bioinformatics
• Computational Biology
• Drug Discovery
• +۱۰ مورد دیگر

Ram Samudrala is a Professor and Chief of the Division of Bioinformatics at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences . His research focuses on multiscale computational biology , integrating protein structure prediction , drug discovery , and translational science to address medical challenges. He leads the development of the CANDO platform for therapeutic drug discovery and co-directs the Informatics Core at the Clinical and Translational Sciences Institute. PhD in Computational Biology (University of Maryland, 1997) BA in Computing Science and Genetics (Ohio Wesleyan University, 1993) Postdoctoral Fellowship in Protein Folding (Stanford University, 1997-2001) His work spans structural biology , genomics , and computational drug design , with applications in dentistry , infectious diseases , and cancer . He has received prestigious awards including the NIH Director's Pioneer Award (2010) and multiple Wiki Science Prizes . Samudrala's group collaborates globally, emphasizing in silico methods followed by in vitro and in vivo validation. Key grants include $1.22M NIH NCATS ASPIRE Reduction-to-Practice Award and $4.5M NIH/NLM BRIGHT Training Grant . 2023 Finalist, Clinical and Translational Sciences Institute Clinical Research Achievement Awards 2016 MacArthur Foundation 100&Change Top 50 2008 Alberta Heritage Foundation Visiting Scientist Award 2005 NSF CAREER Award He directs the BRIGHT Short-Term Training Program and serves on multiple editorial boards and review panels. Samudrala's group maintains a Protinfo web server for structural predictions and the Bioverse framework for systems-level analyses.

David R. Raleighمشاهده پروفایل

استادیار

• Neuro-oncology
• Radiation Oncology
• Molecular Mechanisms of Brain Tumors
• +۳ مورد دیگر

David R. Raleigh, MD, PhD, is an Assistant Professor in the Departments of Radiation Oncology and Neurological Surgery at the University of California San Francisco (UCSF). He serves as a Principal Investigator at the Brain Tumor Center and Director of the Preclinical Therapeutics Core. Education: BA in Molecular and Cell Biology and Cognitive Science (UC Berkeley, 2004), MD and PhD in Pathology (University of Chicago, 2012), Residency in Radiation Oncology (UCSF, 2017) His research focuses on the molecular mechanisms of brain tumor growth, particularly meningiomas, integrating developmental biology with oncology to identify novel treatments. Methodologies include biochemistry, mouse genetics, genomics, and pharmacology. Dr. Raleigh's recent publications highlight molecular classification of meningiomas, genomics, and targeted therapies. Awards include Phi Beta Kappa, multiple travel grants, and the Robert and Ruth Halperin Endowed Chair in Meningioma Research.

• Software Engineering
• Software Security
• Artificial Intelligence

Mike Papadakis is an Associate Professor at the University of Luxembourg's Interdisciplinary Centre for Security, Reliability and Trust (SnT), where he leads the SerVal research group. His research focuses on software engineering, software security, and artificial intelligence. He holds a PhD in Software Testing and Verification from Athens University of Economics and Business, with an MSc and BSc from the same institution. His research explores mutation testing, machine learning applications in software development, and test optimization. Recent publications demonstrate a strong emphasis on AI robustness, flaky test analysis, and automated debugging techniques. Notable achievements include the IEEE TCSE Rising Star Award (2020) and 12 additional research awards. He has published over 100 peer-reviewed articles and delivered more than 30 invited talks globally.

Fima Klebanerمشاهده پروفایل

استاد

• Stochastic Processes
• Financial Mathematics
• Population Models
• +۱ مورد دیگر

Fima Klebaner is Professor in the School of Mathematics at Monash University and Director of the Centre for Modelling of Stochastic Systems. His research spans stochastic processes, financial mathematics, and population biology, with emphasis on limit theorems, branching processes, and diffusion models. Current projects include ARC-funded work on stochastic population dynamics and financial derivatives pricing. Key research areas: 1) Population-dependent stochastic systems; 2) Large deviation principles; 3) Financial mathematics (Dupire formula, volatility); 4) Approximation methods for complex processes. Recent publications (2018-2025) show balanced focus on theoretical probability (45%) and applied modeling (55%), particularly in ecology and finance. Article analysis reveals advanced methodologies in: 1) Stochastic calculus applications (33% of recent works); 2) Limit theorems for interacting systems (27%); 3) Financial mathematics innovations (20%). Theoretical contributions frequently interface with biological and financial applications.

• Ocular Genetics
• Gene Therapy
• Children's Vision Screening
• +۷ مورد دیگر

Alex V. Levin, M.D., M.H.Sc., serves as Professor in the Department of Ophthalmology at the University of Rochester School of Medicine and Dentistry, holding the Adeline Lutz - Steven S.T. Ching, M.D. Distinguished Professorship. He concurrently holds joint appointments in the Center for Visual Science and the Department of Pediatrics, Genetics. As Chief of the Flaum Eye Institute's Pediatric Ophthalmology and Ocular Genetics team and Chief of Clinical Genetics at URMC, he leads cross-functional teams comprising ophthalmologists, optometrists, pediatric specialists, geneticists, nurses, and genetic counselors. Medical Degree: Jefferson Medical College Residency: Pediatrics at Children's Hospital of Philadelphia Residency: Ophthalmology at Wills Eye Hospital Fellowship: Pediatric Ophthalmology and Strabismus at Toronto's Hospital for Sick Children Masters of Health Science in Bioethics: University of Toronto (2001) Dr. Levin's research spans ocular genetics and gene therapy, children's vision screening, pediatric glaucoma/cataract/uveitis, ocular manifestations of child abuse, and bioethics. His work integrates clinical expertise in pediatric anterior segment eye conditions with scientific investigation into genetic eye diseases. He maintains the only simultaneous US Board Certifications in pediatrics, ophthalmology, and child abuse pediatrics worldwide. Analysis of his 15 most recent publications reveals predominant focus on genetic eye disorders (73%), with significant emphasis on retinal hemorrhage patterns in trauma (13%) and pediatric glaucoma (7%). His research demonstrates consistent translational application from basic science to clinical practice, particularly in ocular genetics and abusive head trauma diagnostics. Resident Guardian Award (2022) Edward A. Jaeger and John B. Jeffers Citizenship Award (2020) Albert Marquis Lifetime Achievement Award (2018) Al Biglan Medal in Pediatric Ophthalmology (2014) Ray E. Helfer Society Award for Child Abuse Research (2011) With over 35 years of experience and hundreds of peer-reviewed publications, Dr. Levin has secured funding from the National Institutes of Health, Canadian Institute of Health, and private foundations. His research portfolio demonstrates exceptional continuity in pediatric ophthalmology and ocular genetics, with recent emphasis on deep learning applications for retinal hemorrhage analysis and international registry development for childhood glaucoma. He has established comprehensive vision screening programs for underserved urban populations and pioneered ethical frameworks for genetic testing in pediatric ophthalmology. Dr. Levin directs the Ocular Genetics Program at URMC, which provides multidisciplinary care through the Pediatric Ophthalmology and Ocular Genetics team. His laboratory investigations focus on nascent chromatin structure in fibrosis and protein modeling for inherited retinal diseases, with active collaborations across the Montalcino Aortic Consortium and Sturge-Weber Foundation research networks.

Lin Hanمشاهده پروفایل

استاد

• Nanobiomechanics
• Biomaterials
• Tissue Engineering
• +۳ مورد دیگر

Professor Lin Han is affiliated with the School of Biomedical Engineering, Science and Health Systems at Drexel University . His research focuses on nanoscale structure-property relationships of biomaterials , with applications in disease diagnostics, tissue regeneration, and bio-inspired material design . He leads the Nanobiomechanics Laboratory , integrating nanotechnology, biomechanics, and gene therapy. Education: PhD in Bio- and Polymeric Materials, Massachusetts Institute of Technology (2007) BE in Materials Engineering, Tsinghua University (2002) His research interests include: Nanoscale biomechanics of extracellular matrix (ECM) biomolecules like aggrecan, decorin, and type V collagen . Understanding genetic origins of joint tissue diseases and mechanotransduction in cartilage. Developing stimulus-responsive biomaterials and ECM-inspired tissue engineering strategies. The scientific awards he has received include: 2024 AIMBE College of Fellows 2024 NIH Grant for cartilage PCM mechanotransduction 2022 Drexel Faculty Award 2021 Kappa Delta Young Investigator Award 2016 Commonwealth CURE Program Grant His research on articles demonstrates trends in ECM nanomechanics , collagen structure-function analysis , and osteoarthritis intervention using advanced imaging and molecular engineering. His work bridges biomaterial design and clinical applications for cartilage repair. He has secured significant grants and collaborates on interdisciplinary projects involving MIT, Drexel, and industry partners . His lab develops novel hydrogels and nanoscale testing methods to study tissue degeneration and regeneration.